Hyperfractionated Twice-Daily RT Feasible in Limited Stage SCLC

(MedPage Today) -- Administration of twice-daily thoracic radiotherapy at 60 Gy in 40 fractions had superior overall survival compared with 45 Gy given twice daily in 30 fractions in patients with limited stage small-cell lung cancer (SCLC), researchers...